Article
25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease.
Inflammopharmacology - 1 Apr 2013
Bartels Lars E, Jørgensen Søren P, Bendix Mia, Hvas Christian L, Agnholt Jørgen, Agger Ralf, Dahlerup Jens F
Abstract excerpt
BACKGROUND: In Crohn's disease (CrD), vitamin D may help to balance an exaggerated immune response and thereby improve the disease course. The immunomodulating effects depend on the activation of 25-hydroxy vitamin D3 (25-D3), into 1,25-dihydroxy vitamin D3 (1,25-D3). This activation has previously been shown to take place in dendritic cells (DC) from healthy individuals. We hypothesised that DC from CrD patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
